Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Flutamide and its metabolite can effectively reduce androgen effects.